Growth Metrics

cbdMD (YCBD) Equity Average (2017 - 2025)

cbdMD (YCBD) has disclosed Equity Average for 9 consecutive years, with $8.1 million as the latest value for Q4 2025.

  • Quarterly Equity Average rose 333.49% to $8.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.1 million through Dec 2025, up 333.49% year-over-year, with the annual reading at $4.6 million for FY2025, 16.42% down from the prior year.
  • Equity Average hit $8.1 million in Q4 2025 for cbdMD, up from $6.7 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $96.2 million in Q3 2021 to a low of $1.2 million in Q1 2025.
  • Historically, Equity Average has averaged $34.3 million across 5 years, with a median of $21.6 million in 2023.
  • Biggest five-year swings in Equity Average: plummeted 88.13% in 2024 and later skyrocketed 333.49% in 2025.
  • Year by year, Equity Average stood at $93.8 million in 2021, then crashed by 69.07% to $29.0 million in 2022, then tumbled by 72.3% to $8.0 million in 2023, then plummeted by 76.69% to $1.9 million in 2024, then skyrocketed by 333.49% to $8.1 million in 2025.
  • Business Quant data shows Equity Average for YCBD at $8.1 million in Q4 2025, $6.7 million in Q3 2025, and $3.4 million in Q2 2025.